Concepedia

Hormonal Therapy

Hormonal Therapy is a type of pharmacological intervention within oncology pharmacotherapy that selectively modulates hormone signaling pathways to inhibit the growth of hormone-sensitive solid tumors.

21.6K

Publications

1.3M

Citations

79.7K

Authors

8.9K

Institutions

Publications per year

2017–2026

3.3K

Variants

Endocrine TherapyHormone Therapy

Parents

Children

Publications

21.6K

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Ian F. Tannock, Ronald de Wit, William R. Berry et al. · New England Journal of Medicine · 2004 · 5.7K citations

, , +12

Abiraterone and Increased Survival in Metastatic Prostate Cancer

Johann S. de Bono, Christopher J. Logothetis, Arturo Molina et al. · New England Journal of Medicine · 2011 · 4.4K citations · Full text

, , +17

Tamoxifen for early breast cancer: an overview of the randomised trials

The Lancet · 1998 · 4.1K citations

, , +9

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Daniel P. Petrylak, Catherine M. Tangen, Maha Hussain et al. · New England Journal of Medicine · 2004 · 3.7K citations · Full text

, , +13

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Johann S. de Bono, Stéphane Oudard, Mustafa Özgüroğlu et al. · The Lancet · 2010 · 3.3K citations

, , +16

1–5 of 21.6K

Authors

79.7K

  1. MD
    Mitch Dowsett

    Royal Marsden Hospital, United Kingdom

    190 publications · 23.8K citations

    78

    h-index

  2. VC
    V. Craig Jordan

    University of Wisconsin–Madison, United States

    119 publications · 10.5K citations

    53

    h-index

  3. AV
    Andrew V. Schally

    Tulane University, United States

    167 publications · 7.7K citations

    51

    h-index

  4. JS
    Johann S. de Bono

    Institute of Cancer Research, United Kingdom

    81 publications · 24.6K citations

    47

    h-index

  5. AG
    Aron Goldhirsch

    European Institute of Oncology, Italy

    80 publications · 10.2K citations

    47

    h-index

1–5 of 79.7K

Institutions

8.9K

  1. Harvard University

    Cambridge, United States

    109 h-index

    1.2K publications

    163.5K citations

  2. The University of Texas MD Anderson Cancer Center

    Houston, United States

    105 h-index

    1.8K publications

    292.2K citations

  3. Dana-Farber Cancer Institute

    Boston, United States

    99 h-index

    1.4K publications

    179.1K citations

  4. Massachusetts General Hospital

    Boston, United States

    96 h-index

    751 publications

    104K citations

  5. Memorial Sloan Kettering Cancer Center

    New York, United States

    92 h-index

    1.4K publications

    202.5K citations

  6. University of California, San Francisco

    San Francisco, United States

    88 h-index

    969 publications

    100.1K citations

  7. Royal Marsden Hospital

    London, United Kingdom

    84 h-index

    740 publications

    100.4K citations

  8. University of California, Los Angeles

    Los Angeles, United States

    83 h-index

    556 publications

    71.2K citations

1–8 of 8.9K

Venues

  1. Journal of Clinical Oncology

    789 publications · 107K citations

    178

    h-index

  2. PubMed

    Repository · 2.3K publications · 114.3K citations

    139

    h-index

  3. The Journal of Clinical Endocrinology & Metabolism

    JCEM · 754 publications · 59.7K citations

    126

    h-index

  4. New England Journal of Medicine

    NEJM · 130 publications · 90.5K citations

    95

    h-index

  5. Cancer

    489 publications · 33.4K citations

    94

    h-index

1–5